Lung Disease Associated with Orally Administered Mesalamine for Ulcerative Colitis

Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis

1987 • 2,734 citations

AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINE

1977 • 815 citations

Bronchial disease in ulcerative colitis.

1980 • 145 citations

Sulphasalazine induced lung disease

1972 • 107 citations

Advances in Drug Therapy for Inflammatory Bowel Disease

1990 • 97 citations

Sulphasalazine: A Review of 40 Years?? Experience

1986 • 97 citations

Mesalazine A Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential in Chronic Inflammatory Bowel Disease

1989 • 78 citations

Sulfasalazine-induced lupus erythematosus

1988 • 76 citations

Fibrosing alveolitis and treatment with sulphasalazine

1974 • 68 citations

Pulmonary Infiltrates and Eosinophilia Associated With Sulfasalazine

1984 • 55 citations

Respiratory disease due to sulphasalazine

1974 • 46 citations

Mesalazine: A Global Safety Evaluation

1990 • 35 citations

FIBROSING ALVEOLITIS DUE TO SULPHASALAZINE IN A PATIENT WITH RHEUMATOID ARTHRITIS

1990 • 26 citations

Interstitial pneumonia due to sulfasalazine.

1983 • 15 citations